Albuterol and Neoplasm progression - a phase IV clinical study of FDA data

Summary:

Neoplasm progression is reported as a side effect among people who take Albuterol (albuterol), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Zometa, and have High blood pressure.

The phase IV clinical study analyzes which people have Neoplasm progression when taking Albuterol. It is created by eHealthMe based on reports of 159,093 people who have side effects when taking Albuterol from the FDA, and is updated regularly.

What is Albuterol?

Albuterol has active ingredients of albuterol. It is often used in asthma. eHealthMe is studying from 161,052 Albuterol users. Check the latest studies of Albuterol.

What is Neoplasm progression?

Neoplasm progression (growth of tumour) is found to be associated with 1,069 drugs and 912 conditions by eHealthMe. Check the latest studies of Neoplasm progression.

On Jul, 07, 2026

159,093 people reported to have side effects when taking Albuterol.
Among them, 169 people (0.11%) have Neoplasm progression.

Could Albuterol cause Neoplasm progression?

Among these 169 people:

How long have people been on Albuterol when they have Neoplasm progression? *

Click here to view more results

What is the gender of people who have Neoplasm progression when taking Albuterol? *

Click here to view

What is the age of people who have Neoplasm progression when taking Albuterol? *

Click here to view more results

* Approximation only. Some reports may have incomplete information.

Do you take Albuterol and have Neoplasm progression?

- Check whether Neoplasm progression is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Albuterol:

Albuterol (161,052 reports)

Neoplasm progression treatments and more:

Neoplasm progression (41,778 reports)

How severe was Neoplasm progression and when was it recovered:

Neoplasm progression in Albuterol

Expand to all the drugs that have ingredients of albuterol:

Neoplasm progression and drugs with ingredients of albuterol (200 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Albuterol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Neoplasm progression:

Neoplasm progression (1,069 drugs)

Browse all the conditions that are associated with Neoplasm progression:

Neoplasm progression (912 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on albuterol (the active ingredients of Albuterol) and Albuterol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.